Advertisement

Topics

Organogenesis Incorporated Company Profile

09:08 EDT 23rd September 2017 | BioPortfolio

Organogenesis Inc. designs, develops and manufactures medical therapeutics containing living cells and/or natural connective tissue. The company was formed to advance and apply the emerging field of tissue engineering to majormedical needs. Organogenesis' lead product, Apligraf(R), was launched in the US in June 1998. Apligraf is the only mass-manufactured product containing living human cells to show efficacy in a controlled study and gain FDA PMA approval.

Location

150 Dan Road
Canton
MA
02021
United States of America

Contact

Phone: 617 781 0775
Fax: 617 781 0440


News Articles [22 Associated News Articles listed on BioPortfolio]

Eastward Capital provides $20M facility to Organogenesis

Canton, Mass.-based advanced wound care innovation and technologies developer Organogenesis has secured a financing facility  -More- 

Organogenesis enters $25mm credit facility agreement with SVB

Regenerative medicine firm Organogenesis Inc. entered into a $25mm revolving line of credit with Silicon Valley Bank (SVB). The company, which develops biomaterials for orthopedics, advanced wound car...

Organogenesis Closes on a $20 Million Facility from Eastward Capital Partners

CANTON, Mass., May 22, 2017 /PRNewswire/ -- Organogenesis Inc., a commercial leader in the field of regenerative medicine focusing on advanced wound care and surgical biologics, today closed a $2...

Eastward Capital provides $20mm facility to Organogenesis

Organogenesis Inc. (biomaterials for regenerative medicine) closed a $20mm financing facility provided by Eastward Capital. The funding comes just a month after the company secured a $25mm credit faci...

Organogenesis Closes On A $20 Million Facility From

  Life Sciences Jobs   ...

Organogenesis Inc. Sponsors American Podiatric Medical Association Education Programs, Annual Scientific Meeting

CANTON, Mass., July 27, 2017 /PRNewswire/ -- Organogenesis Inc. today announced its 2017 sponsorship of the American Podiatric Medical Association (APMA), including support for three of the APMA'...

Organogenesis Shares Best Practices for Rapid Sterility Detection Techniques for Cell-Based Therapies at Future Cell Therapy Commercialization Summit

CANTON, Mass., June 26, 2017 /PRNewswire/ -- Cell therapy scientists, researchers and product developers will learn about advanced rapid sterility detection techniques employed by Organogenesis Inc. a...

PuraPly™ Antimicrobial Named One of Top 10 Innovations in Podiatry

CANTON, Mass., July 13, 2017 /PRNewswire/ -- PuraPlyTM Antimicrobial (PuraPlyTM AM), an FDA 510(k)-cleared wound management product from Organogenesis Inc., has been named one of the "Top 10 Inno...

PubMed Articles [56 Associated PubMed Articles listed on BioPortfolio]

Cultivar-Dependent Direct Organogenesis of Date Palm from Shoot Tip Explants.

A number of public and private laboratories are working on date palm micropropagation to meet the increasing worldwide demand for date palm planting material. A standardized direct organogenesis proto...

Optimized Direct Organogenesis from Shoot Tip Explants of Date Palm.

In vitro propagation is an available alternative to produce uniform and good-quality planting material to establish large-scale date palm cultivation in a short time. This study was carried out to ach...

Recent patents in plant organogenesis.

Cellular and molecular oxidative stress-related effects in uterine myometrial and trophoblast-decidual tissues after perigestational alcohol intake up to early mouse organogenesis.

The placenta plays a major role in embryo-fetal defects and intrauterine growth retardation after maternal alcohol consumption. Our aims were to determine the oxidative status and cellular and molecul...

Transcriptomic analysis of thalidomide challenged chick embryo suggests possible link between impaired vasculogenesis and defective organogenesis.

Since the conception of thalidomide as a teratogen approximately 30 hypotheses have been put forward to explain the developmental toxicity of the molecule. However, no systems biology approach has bee...

Clinical Trials [0 Results]

None

Companies [39 Associated Companies listed on BioPortfolio]

Organogenesis Incorporated

Organogenesis Inc. designs, develops and manufactures medical therapeutics containing living cells and/or natural connective tissue. The company was formed to advance and apply the emerging field of ...

Organogenesis, Inc.

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a leading regenerative medicine company focused in the areas of bioactive wound healing, oral regeneration and biosurgery. The co...

Organogenesis Inc.

Organogenesis Inc. DescriptorA leading tissue regeneration company with the unique skill set to take complex, living therapies from R&D, through manufacturing, to successful commercialization.MissionT...

Organogenesis

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a leading regenerative medicine company focused in the areas of bioactive wound healing, oral regeneration and biosurgery. The co...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

More Information about "Organogenesis Incorporated" on BioPortfolio

We have published hundreds of Organogenesis Incorporated news stories on BioPortfolio along with dozens of Organogenesis Incorporated Clinical Trials and PubMed Articles about Organogenesis Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Organogenesis Incorporated Companies in our database. You can also find out about relevant Organogenesis Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record